SALT LAKE CITY, Dec. 21, 2017 /PRNewswire/ -- A new cancer treatment technology is one step closer to Salt Lake City. Today Huntsman Cancer Institute (HCI) at the University of Utah (U of U) announced a plan to add a proton therapy center to its Cancer Hospital. Huntsman Cancer Foundation, HCI, and the U of U have agreed to dedicate the required funding to the project. The plan will now move forward to the next steps of design and vendor selection.

Proton therapy is a type of radiation therapy, a cancer treatment that delivers beams of radiation to shrink a tumor. Proton treatment has been found to be an effective radiation therapy option for numerous types of cancers. This includes childhood cancers, and adult cancers such as head and neck tumors, brain tumors, prostate cancer, lymphomas, pancreas cancer, and esophageal cancer. Proton therapy is often the favored course of treatment when a tumor is close to an important vital structure, like the spinal cord or brain stem.

HCI will use Intensity Modulated Proton Therapy (IMPT) technology for their center. IMPT delivers precise, pencil-thin beams of protons to a tumor, providing an advantage over earlier scattered-beam therapy that is in place in other proton therapy centers. This helps to ensure the maximum dose of radiation to the tumor, while minimizing the damage to surrounding healthy tissues. As a result, patients suffer from fewer side effects from their radiation. Experience with early proton therapy machines has shown that patients for whom this treatment is appropriate benefit from reduced side effects when treated with proton therapy versus other radiation therapy approaches. And with IMPT, the team at HCI expects the benefit to patients in terms of reduced side effects to be even greater than with earlier proton technology.
"An intensity modulated proton therapy center in Utah adds a critical new tool to our array of outstanding radiation therapy technology and research here at HCI," said Dennis Shrieve, MD, PhD, professor and chair of Radiation Oncology at the U of U and investigator at HCI. "This new technology will allow patients who will most benefit from proton therapy to avoid disruptive travel far from home. Further, HCI will be able to contribute to research in most effective uses of intensity modulated proton therapy technology in the treatment of cancer."

The nearest proton centers to Salt Lake City are currently located in southern Arizona and central California, approximately a 10-hour drive away. Patients who are given proton therapy may need to plan for a treatment course that occurs five days a week and spans four to eight weeks. HCI estimates it refers more than 40 patients per year to centers out of state.

Rad Oncology Homepage